Replies to post #326 on Idenix Pharmaceuticals (IDIX)

[friendofthedevil]

Thank you for the report. Very good.

Something I may have missed since following this stock (largely thru this mb), and have recently looked for, is a description of the trial in resistant (or relapsed responders) HCV pts. Specifically, can anyone refer me to a description of the resistant or relapsed cohort, the treatment regimen, and the results. Thank you.